Form 4: Integra LifeSciences: Director Granted RSUs

Integra LifeSciences Holdings Corp. reports a grant of 17,700 Restricted Stock Units (RSUs) to Director Jeffrey A. Graves.

Summary

• Director Jeffrey A. Graves was granted 17,700 Restricted Stock Units (RSUs) on May 7, 2026.
• These RSUs are part of the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan.
• Each RSU represents a contingent right to receive one share of IART common stock.
• The RSUs will vest in full on the one-year anniversary of the grant date, May 7, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard equity grant to a director, which is a routine event for publicly traded companies and does not inherently signal positive or negative performance.

Positives

• Grant of equity awards to a director, indicating continued incentive and alignment with company performance.
• The grant is made under an existing equity incentive plan, suggesting a structured approach to compensation.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports a transaction related to executive compensation.

Industry Context

StockSavvy.ai notes that grants of equity awards like RSUs to directors are a common practice in the life sciences industry to attract, retain, and incentivize key leadership, aligning their interests with shareholders.

Related Party Transactions

• Grant of 17,700 Restricted Stock Units (RSUs) to Director Jeffrey A. Graves.

Stakeholder Impact

• Shareholders: The grant of RSUs represents a form of compensation that dilutes existing share ownership slightly upon vesting, but also serves to retain key leadership aligned with shareholder interests.
• Employees: This filing is specific to director compensation and does not directly impact general employee compensation structures.
• Management: The grant reinforces the compensation strategy for key executives and directors.

Next Steps

• Vesting of 17,700 RSUs on May 7, 2027, contingent on continued service.

Key Dates

Keywords

Integra LifeSciences, IART, Form 4, Restricted Stock Units, RSUs, Equity Incentive Plan, Director Compensation, Beneficial Ownership